-
News | 2023.06.14
DARRI at the Hellenic Pasteur Institute: Innovation and Technology Transfer Workshop
From June 26 to 29, 2023, The Hellenic Pasteur Institute, member of the Pasteur Network, is organizing a workshop on technology transfer in biological sciences and public health. Targeting young researchers from all over the world, it will offer an opportunity to immerse in the innovation ecosystem. Some members of Institut Pasteur's Technology Transfer and Industrial Partnership Department (...
-
News | 2026.03.12
COVID-19: a new strategy under investigation to tackle all variants
Scientists at the Institut Pasteur have developed an innovative strategy to combat SARS-CoV-2. Rather than targeting a virus in constant mutation, they propose blocking the gateway used by the virus to penetrate our cells. This is achieved by nasal administration of an antibody that protects against all known variants, paving the way for new therapies aimed at vulnerable individuals. This work,...
-
News | 2019.11.22
2018 Activity Report for the Pasteur Microbes and Health Carnot Institute
The Activity Report for the Pasteur Microbes and Health Carnot Institute has now been published. It looks back at the main activities carried out in 2018, in synergy with the Institut Pasteur's Research Applications and Industrial Relations Department (DARRI). These activities are in line with the Institut Pasteur's 2019-2023 Strategic Plan.The Pasteur Microbes and Health (Pasteur MS) Carnot...
-
Article | 2016.12.02
Innovation and technology transfer
Innovation development and technology transfer are promoted by the Institut Pasteur through its multidisciplinary and transversal approach to research.
-
News | 2021.05.06
Creation of the startup SPIKIMM to develop monoclonal antibodies as an innovative treatment for Covid-19
The Institut Pasteur has recently signed an exclusive worldwide license agreement with the new biotech start-up SpikImm SAS, created by Truffle Capital, for the development of anti-SARS-CoV-2 (Covid-19) monoclonal antibodies for therapeutic and diagnostic use.Monoclonal antibody therapy is one of the most innovative ways currently available to treat Covid-19 patients and prevent severe forms of...
-
News | 2026.01.15
Enodia Therapeutics: €20.7 million in funding to translate Institut Pasteur discovery into innovative therapies
Enodia Therapeutics, a startup spun out from Institut Pasteur and launched in February 2025, has raised €20.7 million in a seed funding round co-led by Elaia, Pfizer Ventures, and Bpifrance through its InnoBio fund, with participation from Wallonie Entreprendre, Argobio Studio, MACSF, the Institut Pasteur, InvestSud, Sambrinvest and Mission BioCapital. The successful funding round, which...
-
News | 2022.07.19
A successful first edition of Pasteur Innov Day
The first Pasteur Innov Day, held on campus on July 7 and organized by the Department of Technology, the Technology Transfer and Industrial Partnership Department (DARRI) and the management team at the institut Pasteur Microbes & Santé, was attended by around a hundred industrial and academic partners. "There is no innovation without technology" was the motto of a day that provided plenty of...
-
News | 2025.04.29
Advanced HPV RNA-Seq Test developed by the Institut Pasteur : exclusive license signed with ABL Diagnostics
The Institut Pasteur, a Carnot institute since 2007, and ABL Diagnostics, a Euronext-listed leader in molecular diagnostics, recently signed a licensing agreement for the integration of the innovative HPV RNA sequencing technology into ABL Diagnostics solutions, which will produce and market the test.HPV RNA-Seq is a cutting-edge diagnostic method that enhances the detection and typing of high-...
-
Article | 2017.05.11
My PhD at the Institut Pasteur
At the Institut Pasteur, we welcome doctoral students from Master's programs, French doctoral schools and international partner universities for a high-level scientific training guided by strong social and ethical values.
-
News | 2019.06.04
Icypro, an advanced bioimage analysis platform for health technology professionals
The aim of the Icypro project is to transfer the expertise and advanced bioimage analysis solutions developed at the Institut Pasteur to fields where they will have a real impact for patients, such as diagnostics, medtech and drug discovery. On May 21, 2019, all the Icypro project partners and funders gathered at the Institut Pasteur for the official project launch.Winner of the 2018 SESAME...